The AIDE Axiom: Rewriting the Economics of World-Changing Ventures in Deep Tech, MedTech, and Pharma - The Martin Trust Center for MIT Entrepreneurship
Deep tech, medtech, and pharma ventures have always faced a decade-long gauntlet of massive capital demands and crushing scientific risk, limiting the pace of breakthroughs. Now, AI is shattering these barriers; by adopting an AI-Driven Enterprise model, founders and investors can turbocharge success rates and democratize deep innovation.| The Martin Trust Center for MIT Entrepreneurship
